SciELO - Scientific Electronic Library Online

 
vol.29 issue2Secondary hypertension: when and how to look for it?Sex-related risk of arrhythmia in takotsubo syndrome author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Cardiología

Print version ISSN 0120-5633

Rev. Colomb. Cardiol. vol.29 no.2 Bogota Jan./Apr. 2022  Epub May 19, 2022

https://doi.org/10.24875/rccar.m22000129 

Cardiología del adulto - Reporte de casos

A rare simultaneous occurrence: Mitral valve endocarditis complicated by iliac saddle and cerebral embolisms

Un incidente simultáneo inusual: endocarditis de la válvula mitral complicada por embolia ilíaca en silla de montar y embolia cerebral

Yavuzer Koza1  * 

Uğur Kaya1 

Enise Armağan-Koza2 

1Department of Cardiology and Cardiovascular Surgery, Faculty of Medicine, Ataturk University

2Department of Anesthesiology, Erzurum Regional Training and Research Hospital. Erzurum, Turkey


Abstract

Infective endocarditis is a severe disease with a high mortality and morbidity, and its clinical heterogeneity is a challenging barrier to rapid diagnosis and treatment. Diagnosis of infective endocarditis is based on clinical, microbiological, and echocardiographic findings; however, a high index of suspicion is mandatory because this disease may present either as an acute, rapidly progressive infection or as a chronic disease. Approximately 20-50% of cases show multiple embolic events as the first presentation of infective endocarditis. We report a patient with a rare case of infective endocarditis complicated with iliac saddle and cerebral embolisms who underwent simultaneous operations for mitral valve endocarditis and iliac embolism.

Keywords Endocarditis; Cerebral embolism; Iliac saddle embolism

Resumen

La endocarditis infecciosa es una enfermedad grave, que conlleva alta morbimortalidad; su heterogeneidad clínica constituye una barrera desafiante para un rápido diagnóstico y tratamiento. El diagnóstico se basa en hallazgos clínicos, microbiológicos y ecocardiográficos; sin embargo, se requiere un alto índice de sospecha ya que esta enfermedad puede debutar ya sea como una infección aguda de rápida evolución o como una enfermedad crónica. Aproximadamente, 20 a 50% de los casos presentan múltiples eventos embólicos como primera manifestación de la endocarditis infecciosa. Se informa de un paciente con un caso inusual de endocarditis infecciosa complicada por embolia ilíaca en silla de montar y embolia cerebral, quien fue sometido a cirugías simultáneas por endocarditis de la válvula mitral y embolia ilíaca.

Palabras clave Endocarditis; Embolia cerebral; Embolia ilíaca en silla de montar

Introduction

Infective endocarditis is associated with a high mortality rate of 15-20% and a 1-year mortality approaching 40%1. Embolism is a major life-threatening complication of endocarditis and often involves major arterial beds, including the lungs, coronary arteries, spleen, bowel, and extremities. Up to 65% of embolic events may involve the central nervous system1,2. Multiple embolic events are rarely encountered, and no previously reported cases have addressed infective endocarditis complicated with iliac saddle and cerebral embolisms.

Case

A 48-year-old man presented at our internal medicine clinic with the complaints of fever, fatigue, and loss of weight and appetite and was transferred to cardiology clinic for an audible cardiac murmur. His medical history was unremarkable, except for hypertension. A physical examination revealed a blood pressure of 140/80 mmHg, pulse rate of 110 beats/min, and body temperature of 38.3°C. He had mild scleral icterus and hepatomegaly. Cardiac auscultation revealed a harsh systolic murmur at the mitral valve area. A transthoracic echocardiogram showed a vegetation (0.9 × 0.3 cm) attached to the anterior fibrotic mitral leaflet (Fig. 1A). No other valves were involved. Laboratory tests showed leukocytosis, an elevated C-reactive protein level of 120 (1-5) mg/dl, and an erythrocyte sedimentation rate of 63 (20-40) mm/h. Urine analysis revealed microscopic hematuria, but a chest radiograph did not reveal any abnormal findings. Three sets of blood culture samples were taken, and empirical antibiotic therapy with vancomycin (40 mg/kg 2 × 1 i.v.) and gentamicin (3 mg/kg 1 × 1 i.v.) was initiated with a diagnosis of native valve endocarditis. Three days after hospitalization, the patient suddenly developed dysphasia, and a brain magnetic resonance imaging revealed multiple embolic infarcts located at the right cerebral hemisphere and the left occipital, parietal, and temporal lobes. On day 5, the patient complained numbness and pain in his lower extremities, and a duplex ultrasonography revealed a saddle embolism at the iliac bifurcation (Fig. 1B).

Figure 1 A: transthoracic echocardiography showing the vegetation (arrow). B: ultrasonographic image of the iliac saddle emboli (arrow). C: the resected embolized material. LA: left atrium. LV: left ventricle. 

The patient underwent an urgent operation. A bilateral femoral artery incision was made and the embolized material was resected by a bilateral femoral embolectomy (Fig. 1C). All surgical instruments were changed and a median sternotomy was performed. The fibrotic mitral valve was replaced with a 29 mm bioprosthetic valve after debridement of vegetations (Fig. 2A). The patient tolerated the surgery well.

Figure 2 A: intraoperative image showing the vegetation (arrow). B: computed tomographic image showing intracerebral hemorrhage (arrow). 

Blood cultures were positive for coagulase-negative Staphylococcus aureus. The patient was started on 1 mg/kg low-molecular-weight heparin after post-operative bleeding control and then on aspirin at post-operative day 10. A 6-week course of intravenous antibiotic treatment (daptomycin 10 mg/kg 1 × 1 i.v. and cloxacillin 2 g/4 h i.v.) was scheduled and continued according to the antibiogram. However, during the hospital stay, the patient developed an intracerebral hemorrhage (Fig. 2B). He underwent an operation in the neurosurgery clinic but, unfortunately, he died 5 days later.

Discussion

Despite diagnostic and therapeutic improvements, infective endocarditis remains associated with a high morbidity and mortality. Up to 90% of patients with infective endocarditis present with fever, often associated with systemic symptoms of chills, poor appetite, and weight loss1. Peripheral septic embolisms are an extremely prevalent phenomenon in infective endocarditis, being present in approximately 45-65% of the cases studied on autopsy. In contrast to posterior leaflet locations, vegetations located at the anterior mitral leaflet are more prone to peripheral embolism, as in the present case. Embolism is also more likely when the vegetations are large (more than 10 mm in length) and highly mobile1,2.

In infective endocarditis, a peripheral septic embolism typically cannot be identified because of the lack of a high index of suspicion2. In our patient, the symptoms and signs were initially attributed to a gastrointestinal malignancy, probably since the patient had no history of previous heart disease. Likewise, weight loss may be the initial clinical presentation of infective endocarditis and should be part of the differential diagnosis in patients who have weight loss of relatively sudden onset and a history of fever and fatigue. The diagnosis of infective endocarditis should not be excluded based on a clinical examination alone. Microbiological analysis and echocardiography are essential for diagnosis. Contrary to popular medical practice, bacteremia in infective endocarditis is continuous, so cultures do not need to be timed with peaks of fever3.

Infective endocarditis is complicated by stroke in 20-40% of cases4. Although the current guidelines recommend surgery to prevent recurrent embolus in patients with a persisting vegetation higher than 10 mm in size, this recommendation is mostly not considered alone in clinical practice. Mitral valve involvement with severe valvular regurgitation or stenosis, vegetation mobility, and S. aureus infection is the other risk factors for embolism2,4,5.

In cases with a high suspicion of infective endocarditis, empirical antibiotic treatment must be started at the earliest time possible, because delays have negative impacts on clinical outcomes. The early initiation of antimicrobial therapy (within 1 week) is associated with a 65% reduction in risk of stroke related to infective endocarditis5.

On the other hand, in a cohort of 1345 patients with infective endocarditis, S. aureus infection and anticoagulant therapy were significantly associated with a larger number of hemorrhagic strokes from hemorrhagic transformations of ischemic lesions even after 1 week of antimicrobial treatment6.

In cases of neurological complications, when cerebral hemorrhage has been excluded and neurological damage is not severe, cardiac surgery can be performed early. Conversely, in cases with large intracranial hemorrhage, the neurological prognosis is poor and surgery must be delayed for at least 1 month. However, if urgent cardiac surgery is needed, close cooperation with the neurosurgical team is essential. After an ischemic stroke, cardiac surgery is not contraindicated unless the neurological prognosis is judged as too poor2,5,7. However, note that surgery can lead to hemorrhagic transformation of ischemic stroke caused by the anticoagulation theraphy used for cardiopulmonary bypass.

The risk of neurological deterioration after valvular surgery has been reported to be low (0-6%), even when surgery is performed very early after the first appearance of neurological symptoms4,7. It has been previously shown that no apparent survival benefit was found in delaying surgery when indicated in infective endocarditis patients after ischemic stroke5,7.

Conclusion

Stroke and peripheral embolism remain one of the most common and often devastating complications of infective endocarditis. Although the clinical heterogeneity of infective endocarditis sometimes prevents early diagnosis and timely treatment, patients who present with fever and with non-specific symptoms such as loss of appetite and weight, as in the present case, should be evaluated for the presence of infective endocarditis.

References

1. Vincent LL, Otto CM. ınfective endocarditis:update on epidemiology, outcomes, and management. Curr Cardiol Rep. 2018;20:86. [ Links ]

2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. AHA/ACC focused update of the 2017 AHA/ACC Guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159-95. [ Links ]

3. Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in ınfective endocarditis. J Am Coll Cardiol. 2017;69:325-44. [ Links ]

4. Yanagawa B, Pettersson GB, Habib G, Ruel M, Saposnik G, Latter DA, et al. Surgical management of ınfective endocarditis complicated by embolic stroke:practical recommendations for clinicians. Circulation. 2016;134:1280-92. [ Links ]

5. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults:diagnosis, antimicrobial therapy, and management of complications:a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435-86. [ Links ]

6. García-Cabrera E, Fernández-Hidalgo N, Almirante B, Ivanova-Georgieva R, Noureddine M, Plata A, et al. Neurological complications of infective endocarditis risk factors, outcome, and impact of cardiac surgery:a multicenter observational study. Circulation. 2013;127:2272-84. [ Links ]

7. Sotero FD, Rosário M, Fonseca AC, Ferro JM. Neurological complications of ınfective endocarditis. Curr Neurol Neurosci Rep. 2019;19:23. [ Links ]

FundingThe authors declare there was no funding provided for this report.

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent. The authors have obtained the written informed consent of the patient’s family or subjects mentioned in the article. The corresponding author is in possession of this document.

Received: February 19, 2020; Accepted: May 26, 2020

*Correspondence: Yavuzer Koza E-mail: yavuzerkoza@hotmail.com

Conflicts of interest

The authors declare they have no conflicts of interests.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open ccess article under the CC BY-NC-ND license